Pfizer to sell its patented drugs at nonprofit price to low-income nations

Pfizer announced on Wednesday that it will now sell all of its patented medicines at a not-for-profit price to 45 of the world’s poorest countries. The drug company has been accused of “pandemic profiteering” over the billions of dollars it’s made over the past few years. Host Marco Werman speaks with Jamie Love of Knowledge Ecology International, an NGO that focuses on the effects of intellectual property on public health, about the significance of this gesture.

Help keep The World going strong!

The article you just read is free because dedicated readers and listeners like you chose to support our nonprofit newsroom. Our team works tirelessly to ensure you hear the latest in international, human-centered reporting every weekday. But our work would not be possible without you. We need your help.

Make a gift today to help us reach our $25,000 goal and keep The World going strong. Every gift will get us one step closer.